There was evidence of an association between brain-PAD and the blood-based biomarker serum NFL: robust linear regression showed that 1 SD increase in serum NFL was associated with a 1·2-year increase in brain-PAD (95% CI 0·9–1·9; appendix p 8). The gene discussed is NEFL; the disease is peripheral arterial disease.